Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis
- 30 June 1995
- journal article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 76 (3) , 230-233
- https://doi.org/10.1016/s0962-8479(05)80010-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A New Serum Tumor Marker, CAM 123-6, Highly Specific to Pulmonary AdenocarcinomaJapanese Journal of Cancer Research, 1994
- Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9International Journal of Cancer, 1994
- Third international workshop on lung tumor and differentiation antigens: Overview of the results of the central data analysisInternational Journal of Cancer, 1994
- Down‐modulation of epidermal growth factor receptor accompanies TNF‐induced differentiation of the DiFi human adenocarcinoma cell line toward a goblet‐like phenotypeJournal of Cellular Physiology, 1993
- Elevation of Tumor-associated Carbohydrate Antigens in Patients with Diffuse PanbronchiolitisAmerican Review of Respiratory Disease, 1993
- KL-6, a Mucin-like Glycoprotein, in Bronchoalveolar Lavage Fluid from Patients with Interstitial Lung DiseaseAmerican Review of Respiratory Disease, 1993
- Circulating Antigen KL-6 and Lactate Dehydrogenase for Monitoring Irradiated Patients with Lung CancerChest, 1992
- Monitoring of Serum KL-6 Antigen in a Patient with Radiation PneumoniaChest, 1992
- Clinical Significance of Serum Levels of a Carbohydrate Antigen, Sialyl SSEA-1, in Patients with Fibrosing Lung DiseaseAmerican Review of Respiratory Disease, 1991
- New Serum Indicator of Interstitial Pneumonitis ActivityChest, 1989